Literature DB >> 11353077

Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.

F Shi1, A Nomden, V Oberle, J B Engberts, D Hoekstra.   

Abstract

Oligonucleotides (ODNs) can be employed as effective gene-specific regulators. However, before ODNs can reach their targets, several physical barriers have to be overcome, as although ODNs may pass cell membranes, most become sequestered in endocytic compartments. Accordingly, sophisticated strategies are required for efficient delivery. Here we have employed a pyridinium-based synthetic amphiphile, called SAINT-2, which carries ODNs into cells in a highly efficient, essentially non-toxic and serum-insensitive manner. Intracellular delivery was examined by monitoring the trafficking of fluorescent ODNs and lipid, and by measuring the effect of specific antisense ODNs on target mRNA and protein levels of the receptor for the neuropeptide corticotropin-releasing factor (CRF-R), expressed in Chinese hamster ovary cells. ODN delivery is independent of lipoplex size, and fluorescently tagged ODNs readily acquire access to the nucleus, whereas the carrier itself remains sequestered in the endosomal-lysosomal pathway. While the release is independent of the presence of serum, it is not observed when serum proteins gain access within the lipoplex, and which likely stabilizes the lipoplex membrane. We propose that the amphiphile-dependent aggregate structure governs complex dissociation, and hence, the biological efficiency of ODNS: We demonstrate an essentially non-toxic and effective antisense-specific down-regulation of the CRF-R, both at the mRNA and protein level.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11353077      PMCID: PMC55445          DOI: 10.1093/nar/29.10.2079

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  33 in total

1.  Intracellular distribution of microinjected antisense oligonucleotides.

Authors:  J P Leonetti; N Mechti; G Degols; C Gagnor; B Lebleu
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

2.  Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.

Authors:  J Carmichael; W G DeGraff; A F Gazdar; J D Minna; J B Mitchell
Journal:  Cancer Res       Date:  1987-02-15       Impact factor: 12.701

3.  Serum as a modulator of lipoplex-mediated gene transfection: dependence of amphiphile, cell type and complex stability.

Authors:  S Audouy; G Molema; L de Leij; D Hoekstra
Journal:  J Gene Med       Date:  2000 Nov-Dec       Impact factor: 4.565

4.  Hydration of lipoplexes commonly used in gene delivery: follow-up by laurdan fluorescence changes and quantification by differential scanning calorimetry.

Authors:  D Hirsch-Lerner; Y Barenholz
Journal:  Biochim Biophys Acta       Date:  1999-11-09

5.  A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus.

Authors:  M Boshart; F Weber; G Jahn; K Dorsch-Häsler; B Fleckenstein; W Schaffner
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

6.  Characterization of oligonucleotide transport into living cells.

Authors:  S L Loke; C A Stein; X H Zhang; K Mori; M Nakanishi; C Subasinghe; J S Cohen; L M Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 7.  Oligodeoxynucleotides as inhibitors of gene expression: a review.

Authors:  C A Stein; J S Cohen
Journal:  Cancer Res       Date:  1988-05-15       Impact factor: 12.701

8.  Use of resonance energy transfer to monitor membrane fusion.

Authors:  D K Struck; D Hoekstra; R E Pagano
Journal:  Biochemistry       Date:  1981-07-07       Impact factor: 3.162

9.  Exposure to an antisense oligonucleotide decreases corticotropin-releasing factor receptor binding in rat pituitary cultures.

Authors:  M J Owens; J J Mulchahey; J W Kasckow; P M Plotsky; C B Nemeroff
Journal:  J Neurochem       Date:  1995-05       Impact factor: 5.372

10.  Salvage of glucosylceramide by recycling after internalization along the pathway of receptor-mediated endocytosis.

Authors:  J W Kok; S Eskelinen; K Hoekstra; D Hoekstra
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

View more
  7 in total

1.  Transfection mediated by pH-sensitive sugar-based gemini surfactants; potential for in vivo gene therapy applications.

Authors:  Luc Wasungu; Marco Scarzello; Gooitzen van Dam; Grietje Molema; Anno Wagenaar; Jan B F N Engberts; Dick Hoekstra
Journal:  J Mol Med (Berl)       Date:  2006-06-08       Impact factor: 4.599

2.  Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions.

Authors:  Fuxin Shi; Luc Wasungu; Anita Nomden; Marc C A Stuart; Evgeny Polushkin; Jan B F N Engberts; Dick Hoekstra
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

3.  Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.

Authors:  Qiang Hu; Marcel B Bally; Thomas D Madden
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

Review 4.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

5.  Phase behavior of cationic amphiphiles and their mixtures with helper lipid influences lipoplex shape, DNA translocation, and transfection efficiency.

Authors:  Inge S Zuhorn; Volker Oberle; Willy H Visser; Jan B F N Engberts; Udo Bakowsky; Evgeny Polushkin; Dick Hoekstra
Journal:  Biophys J       Date:  2002-10       Impact factor: 4.033

6.  Massive and selective delivery of lipid-coated cationic lipoplexes of oligonucleotides targeted in vivo to hepatic endothelial cells.

Authors:  Martin Bartsch; Alida H Weeke-Klimp; Dirk K F Meijer; Gerrit L Scherphof; Jan A A M Kamps
Journal:  Pharm Res       Date:  2002-05       Impact factor: 4.200

Review 7.  Innovations in oligonucleotide drug delivery.

Authors:  Melanie A Lysik; Susanna Wu-Pong
Journal:  J Pharm Sci       Date:  2003-08       Impact factor: 3.534

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.